RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy
Tarek Magdy, Zhengxin Jiang, Mariam Jouni, Hananeh Fonoudi, Davi M. Lyra‐Leite, Gwanghyun Jung, Marisol Romero‐Tejeda, Hui–Hsuan Kuo, K. Ashley Fetterman, Mennat Gharib, Brian T. Burmeister, Mingming Zhao, Yadav Sapkota, Colin J.D. Ross, Bruce Carleton, Daniel Bernstein, Paul W. Burridge
Topics & Concepts
CardiotoxicityAnthracyclineDoxorubicinBiologyPharmacologyAgonistRetinoic acidCancer researchInternal medicineChemotherapyCancerMedicineReceptorCell cultureBiochemistryGeneticsBreast cancerChemotherapy-induced cardiotoxicity and mitigationPARP inhibition in cancer therapyNeuroblastoma Research and Treatments